Metronomic Versus Conventional Chemotherapy in as Maintenance Treatment in mCRC

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The optimum regimen of maintenance treatment after first-line chemotherapy in patients with metastatic colorectal cancer (mCRC) is unknown. This study was designed to determine the efficacy and safety of maintenance treatment with capecitabine metronomic chemotherapy versus conventional chemotherapy.
Epistemonikos ID: 415d3cdb9ebe47e05f1515af3e772f43df0176b2
First added on: Jun 14, 2024